Cadmium-Associated Molecular Signatures in Cancer Cell Models.

Abstract

The exposure of cancer cells to cadmium and its compounds is often associated with the development of more malignant phenotypes, thereby contributing to the acceleration of tumor progression. It is known that cadmium is a transcriptional regulator that induces molecular reprogramming, and therefore the study of differentially expressed genes has enabled the identification and classification of molecular signatures inherent in human neoplastic cells upon cadmium exposure as useful biomarkers that are potentially transferable to clinical research. This review recapitulates selected studies that report the detection of cadmium-associated signatures in breast, gastric, colon, liver, lung, and nasopharyngeal tumor cell models, as specifically demonstrated by individual gene or whole genome expression profiling. Where available, the molecular, biochemical, and/or physiological aspects associated with the targeted gene activation or silencing in the discussed cell models are also outlined.

• Authors: Claudio Luparello
• Journal: Cancers (Cancers (Basel)) Vol. 13 Issue 11 (Jun 05 2021) ISSN: 2072-6694 [Print] Switzerland
• PMID: 34198869 (Publication Type: Journal Article, Review)